These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 38104544)
1. Factors Affecting the Second Complete Atypical Femoral Fracture after the First Atypical Fracture. Tsuchie H; Kasukawa Y; Nozaka K; Kinoshita H; Sasaki K; Aizawa T; Mita M; Ouchi K; Yuasa Y; Miura T; Tomite T; Maekawa S; Abe H; Akagawa M; Shibata N; Fujii M; Takeshima M; Inoue J; Saito H; Miyakoshi N Med Princ Pract; 2024; 33(1):10-20. PubMed ID: 38104544 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of factors affecting the occurrence of second atypical fracture after bone union of the first atypical fracture. Tsuchie H; Miyakoshi N; Kasukawa Y; Nozaka K; Saito K; Kinoshita H; Kobatyashi M; Suzuki N; Aizawa T; Abe H; Maekawa S; Tomite T; Ono Y; Ouchi K; Shibata N; Nagahata I; Takeshima M; Akagawa M; Yuasa Y; Sato C; Shimada Y Bone; 2021 Feb; 143():115671. PubMed ID: 33007529 [TBL] [Abstract][Full Text] [Related]
3. Medical Management of Patients After Atypical Femur Fractures: a Systematic Review and Recommendations From the European Calcified Tissue Society. van de Laarschot DM; McKenna MJ; Abrahamsen B; Langdahl B; Cohen-Solal M; Guañabens N; Eastell R; Ralston SH; Zillikens MC J Clin Endocrinol Metab; 2020 May; 105(5):1682-99. PubMed ID: 31867670 [TBL] [Abstract][Full Text] [Related]
4. Progression of atypical femur stress fracture after discontinuation of bisphosphonate therapy. Gu KD; Ettinger B; Grimsrud CD; Lo JC Osteoporos Int; 2021 Oct; 32(10):2119-2123. PubMed ID: 33914104 [TBL] [Abstract][Full Text] [Related]
5. Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide. Miyakoshi N; Aizawa T; Sasaki S; Ando S; Maekawa S; Aonuma H; Tsuchie H; Sasaki H; Kasukawa Y; Shimada Y J Bone Miner Metab; 2015 Sep; 33(5):553-9. PubMed ID: 25227287 [TBL] [Abstract][Full Text] [Related]
6. Atypical femoral fracture associated with bone-modifying agent for bone metastasis of breast cancer: A report of two cases. Tateiwa D; Outani H; Iwasa S; Imura Y; Tanaka T; Oshima K; Naka N; Araki N J Orthop Surg (Hong Kong); 2017; 25(3):2309499017727916. PubMed ID: 28844196 [TBL] [Abstract][Full Text] [Related]
7. Critical differences between subtrochanteric and diaphyseal atypical femoral fractures: analyses of 51 cases at a single institution in Korean population. Cho YJ; Kang KC; Chun YS; Rhyu KH; Kim SJ; Jang TS Arch Osteoporos; 2018 May; 13(1):53. PubMed ID: 29725835 [TBL] [Abstract][Full Text] [Related]
8. The effects of teriparatide on acceleration of bone healing following atypical femoral fracture: comparison between daily and weekly administration. Tsuchie H; Miyakoshi N; Iba K; Kasukawa Y; Nozaka K; Dohke T; Kosukegawa I; Aizawa T; Maekawa S; Abe H; Takeshima M; Tomite T; Segawa T; Ouchi K; Kinoshita H; Suzuki M; Yamashita T; Shimada Y Osteoporos Int; 2018 Dec; 29(12):2659-2665. PubMed ID: 30105400 [TBL] [Abstract][Full Text] [Related]
9. Trends in the incidence of atypical femoral fractures and bisphosphonate therapy. Clout A; Narayanasamy N; Harris I J Orthop Surg (Hong Kong); 2016 Apr; 24(1):36-40. PubMed ID: 27122510 [TBL] [Abstract][Full Text] [Related]
10. Audit of Atypical Femoral Fractures and a Description of Some of Their Features. Lian K; Trollip J; Sandhu S; Moosavi M; Gill A; Kendler D; Dian L; Lentle B Can Assoc Radiol J; 2016 Feb; 67(1):69-75. PubMed ID: 26800621 [TBL] [Abstract][Full Text] [Related]
11. Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur. Greenspan SL; Vujevich K; Britton C; Herradura A; Gruen G; Tarkin I; Siska P; Hamlin B; Perera S Osteoporos Int; 2018 Feb; 29(2):501-506. PubMed ID: 29085957 [TBL] [Abstract][Full Text] [Related]
12. Atypical femoral fracture mimicking lumbar radiculopathy in two patients taking bisphosphonate long-term: A case report. Tsuchiya K; Okano I; Shiose K; Kudo Y; Hayakawa C; Kuroda T; Toyone T; Inagaki K BMC Musculoskelet Disord; 2022 Dec; 23(1):1103. PubMed ID: 36528778 [TBL] [Abstract][Full Text] [Related]
13. Conservative treatment of recurrent symptoms of an incomplete, atypical femoral fracture associated with glucocorticoid, bisphosphonate, and denosumab therapy in a patient with chronic obstructive pulmonary disease. Lai KH; Chiang CY; Yang RS; Yang KC; Wu CC Acta Clin Belg; 2019 Oct; 74(5):370-374. PubMed ID: 30336748 [No Abstract] [Full Text] [Related]
14. Lateral Cortical Thickening and Bone Heterogeneity of the Subtrochanteric Femur Measured With Quantitative CT as Indicators for Early Detection of Atypical Femoral Fractures in Long-Term Bisphosphonate Users. Lee SH; Lee YH; Suh JS AJR Am J Roentgenol; 2017 Oct; 209(4):867-873. PubMed ID: 28796551 [TBL] [Abstract][Full Text] [Related]
15. Sequential treatment with teriparatide and strontium ranelate in a postmenopausal woman with atypical femoral fractures after long-term bisphosphonate administration. Lampropoulou-Adamidou K; Tournis S; Balanika A; Antoniou I; Stathopoulos IP; Baltas C; Triantafillopoulos IK; Papaioannou NA Hormones (Athens); 2013; 12(4):591-7. PubMed ID: 24457408 [TBL] [Abstract][Full Text] [Related]
16. Study of Atypical Femoral Fracture Cases Coupled in a Multicenter Study. Zenke Y; Ikeda S; Fukuda F; Tanaka M; Tanaka H; Hirano F; Sakai A J UOEH; 2016 Sep; 38(3):207-14. PubMed ID: 27627968 [TBL] [Abstract][Full Text] [Related]
17. Peri-implant atypical femoral fracture after nail or plate osteosynthesis. Kim JW; Oh CW; Park KH; Oh JK; Yoon YC; Kim JK J Orthop Sci; 2022 Jul; 27(4):866-875. PubMed ID: 34052080 [TBL] [Abstract][Full Text] [Related]
18. A proposal for an atypical femur fracture treatment and prevention clinical practice guideline. Dell R; Greene D Osteoporos Int; 2018 Jun; 29(6):1277-1283. PubMed ID: 29675745 [TBL] [Abstract][Full Text] [Related]
19. Atypical femoral fracture in a bisphosphonate-naïve patient on denosumab for osteoporosis. Kumar S; Chang R; Reyes M; Diamond T Arch Osteoporos; 2022 Oct; 17(1):131. PubMed ID: 36180610 [TBL] [Abstract][Full Text] [Related]
20. Is vitamin K Wang B; Tang J; Weng S; Chen L; Wu Z; Xie Z; Yang L J Int Med Res; 2021 Apr; 49(4):3000605211001643. PubMed ID: 33845598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]